These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 16641601)

  • 1. Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut.
    Lee KM; Baris D; Zhang Y; Hosgood HD; Menashe I; Yeager M; Zahm SH; Wang SS; Purdue MP; Chanock S; Zheng T; Rothman N; Lan Q
    Am J Hematol; 2010 Aug; 85(8):560-3. PubMed ID: 20568250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
    Rose JE; Behm FM; Drgon T; Johnson C; Uhl GR
    Mol Med; 2010; 16(7-8):247-53. PubMed ID: 20379614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.
    Hosgood HD; Zhang L; Shen M; Berndt SI; Vermeulen R; Li G; Yin S; Yeager M; Yuenger J; Rothman N; Chanock S; Smith M; Lan Q
    Occup Environ Med; 2009 Dec; 66(12):848-53. PubMed ID: 19773279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of a cDNA encoding the human homolog of tumor necrosis factor receptor-associated factor 5 (TRAF5).
    Mizushima S; Fujita M; Ishida T; Azuma S; Kato K; Hirai M; Otsuka M; Yamamoto T; Inoue J
    Gene; 1998 Jan; 207(2):135-40. PubMed ID: 9511754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources.
    Jung W; Krueger S; Renner C; Gause A; Sahin U; Trümper L; Pfreundschuh M
    Mol Immunol; 1994 Dec; 31(17):1329-34. PubMed ID: 7527901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis.
    Chen Y; Tai Q; Hong S; Kong Y; Shang Y; Liang W; Guo Z; He X
    Transplantation; 2012 Nov; 94(9):911-8. PubMed ID: 23052636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome.
    Ypsilantis E; Key T; Bradley JA; Morgan CH; Tsui S; Parameshwar J; Taylor CJ
    J Heart Lung Transplant; 2009 Nov; 28(11):1206-10. PubMed ID: 19782609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation.
    Heinemann FM; Rebmann V; Witzke O; Philipp T; Broelsch CE; Grosse-Wilde H
    Transplantation; 2007 Mar; 83(6):706-11. PubMed ID: 17414702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
    Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A
    Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodies.
    Vaidya S; Partlow D; Barnes T; Gugliuzza K
    Transplantation; 2006 Dec; 82(12):1606-9. PubMed ID: 17198244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation.
    Frisaldi E; Conca R; Magistroni P; Fasano ME; Mazzola G; Patanè F; Zingarelli E; Dall'omo AM; Brusco A; Amoroso A
    Transplantation; 2006 Apr; 81(8):1153-6. PubMed ID: 16641601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD30 for the prediction and detection of kidney transplant rejection.
    Arjona A
    Drug News Perspect; 2009 Sep; 22(7):409-13. PubMed ID: 19890498
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.